Repression of PXR-mediated induction of hepatic CYP3A gene expression by protein kinase C

被引:85
|
作者
Ding, XS [1 ]
Staudinger, JL [1 ]
机构
[1] Univ Kansas, Lawrence, KS 66045 USA
关键词
pregnane X receptor; CYP3A; PMA; PCN; PKC; inflammation;
D O I
10.1016/j.bcp.2004.11.025
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Pregnane X receptor (PXR, NR112) regulates the inducible expression of the 3A sub-family of cytochrome P450 genes (CYP3A). CYP3A enzymes are responsible for the oxidative metabolism of a wide array of endobiotic and xenobiotic compounds. Hepatic CYP3A gene expression is rapidly down-regulated during inflammation and sepsis. There are twelve protein kinase C (PKC) isoforms, classified into three subfamilies according to the structure of the N-terminal regulatory domain and their sensitivity to calcium and diacylglycerol. It is now well accepted that cytokine stimulation of hepatocytes increases intracellular PKC activity during inflammation and sepsis. We show here that protein kinase C alpha (PKCalpha) and phorbol ester-dependent PKC signaling dramatically repressed PXR activity in both, cell-based reporter gene assays and in hepatocytes. Moreover, treatment with the protein phosphatase PP1/PP2A inhibitor okadaic acid (OA) totally abolished PXR activity in reporter gene assays and in cultured hepatocytes. In mammalian two-hybrid assays, treatment with phorbol 12-myristate 13-acetate (PMA) increased the strength of interaction between PXR and the nuclear receptor co-repressor protein (NCoR). Treatment with PMA also abolished the ligand-dependent interaction between PXR and the steroid receptor co-activator 1 protein (SRC 1). Our findings suggest that activation of the protein kinase C signaling pathway represses PXR activity through alterations in PXR-protein co-factor complexes, possibly through direct alterations in the phosphorylation status of one or all of these proteins. In addition, our data potentially provide important insights into the molecular mechanism of the repression of hepatic CYP3A gene expression that occurs during the inflammatory response. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:867 / 873
页数:7
相关论文
共 50 条
  • [21] Hepatic CYP3A and PXR expression after long-term treatment with GnRH analogs
    Skowronek, R.
    Czekaj, P.
    Suszka-Switek, A.
    Bryzek, A.
    Plewka, D.
    Czech, E.
    Wiaderkiewicz, R.
    FEBS JOURNAL, 2009, 276 : 345 - 345
  • [22] PXR-mediated P-glycoprotein induction by small molecule tyrosine kinase inhibitors
    Harmsen, S.
    Meijerman, I.
    Maas-Bakker, R. F.
    Beijnen, J. H.
    Schellens, J. H. M.
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2013, 48 (4-5) : 644 - 649
  • [23] PXR-mediated transcriptional activation of CYP3A4 by cryptotanshinone and tanshinone IIA
    Yu, Chunna
    Ye, Shanshan
    Sun, Hongying
    Liu, Yao
    Gao, Lingbo
    Shen, Chaofeng
    Chen, Shuqing
    Zeng, Su
    CHEMICO-BIOLOGICAL INTERACTIONS, 2009, 177 (01) : 58 - 64
  • [24] Human PXR-mediated transcriptional activation of CYP3A4 by 'Fuzi' extracts
    Huang, Guangyao
    Yang, Liang
    Zhang, Zhaoyan
    Ren, Sijia
    Tang, Xianglin
    Zhou, Wei
    Wang, Yuguang
    Ma, Zengchun
    Gao, Shan
    Gao, Yue
    TOXICOLOGY MECHANISMS AND METHODS, 2019, 29 (03) : 155 - 164
  • [25] Co-regulation of CYP3A and PXR gene expression in rat and human hepatoma cells
    Fery, Y.
    Mueller, S. O.
    Schrenk, D.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2007, 375 : 73 - 73
  • [26] Quantitative analysis for induction of CYP3A in a new double humanized mice of PXR/SXR (knock-in) and CYP3A (transchromosomic)
    Kuze, Jiro
    Kobayashi, Kaoru
    Takehara, Shoko
    Satoh, Daisuke
    Mutoh, Toshiharu
    Chiba, Masato
    Takano, Kanako
    Igarashi, Katsuhide
    Kitajima, Satoshi
    Kanno, Jun
    Chiba, Kan
    Oshimura, Mitsuo
    Kazuki, Yasuhiro
    DRUG METABOLISM REVIEWS, 2015, 47 : 124 - 124
  • [27] Milk Thistle's Active Components Silybin and Isosilybin: Novel Inhibitors of PXR-Mediated CYP3A4 Induction
    Mooiman, Kim D.
    Maas-Bakker, Roel F.
    Moret, Ed E.
    Beijnen, Jos H.
    Schellens, Jan H. M.
    Meijerman, Irma
    DRUG METABOLISM AND DISPOSITION, 2013, 41 (08) : 1494 - 1504
  • [28] Variability in PXR-mediated induction of CYP3A4 by commercial preparations and dry extracts of St. John’s wort
    Ute Gödtel-Armbrust
    Annegret Metzger
    Ulrike Kroll
    Olaf Kelber
    Leszek Wojnowski
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2007, 375 : 377 - 382
  • [29] Organotin compound DBDCT induces CYP3A suppression through NF-κB-mediated repression of PXR activity
    Li, Yunlan
    Lin, Niu
    Ji, Xiaoqing
    Mai, Jiaqi
    Li, Qingshan
    METALLOMICS, 2019, 11 (05) : 936 - 948
  • [30] Variability in PXR-mediated induction of CYP3A4 by commercial preparations and dry extracts of St. John's wort
    Goedtel-Armbrust, Ute
    Metzger, Annegret
    Kroll, Ulrike
    Kelber, Olaf
    Wojnowski, Leszek
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2007, 375 (06) : 377 - 382